Molina Healthcare (NYSE:MOH) Receives "Overweight" Rating from Cantor Fitzgerald

Molina Healthcare (NYSE:MOH - Get Free Report)'s stock had its "overweight" rating reaffirmed by research analysts at Cantor Fitzgerald in a report released on Thursday, Benzinga reports. They currently have a $406.00 price target on the stock. Cantor Fitzgerald's price objective suggests a potential upside of 8.18% from the company's current price.

A number of other equities analysts have also recently commented on MOH. UBS Group boosted their price target on shares of Molina Healthcare from $350.00 to $380.00 and gave the stock a "neutral" rating in a research note on Thursday, December 21st. Bank of America cut shares of Molina Healthcare from a "neutral" rating to an "underperform" rating and set a $439.00 price target for the company. in a research note on Thursday, March 28th. Wells Fargo & Company boosted their price target on shares of Molina Healthcare from $420.00 to $440.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 20th. StockNews.com cut shares of Molina Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Thursday, February 8th. Finally, Barclays began coverage on shares of Molina Healthcare in a report on Wednesday, March 6th. They issued an "equal weight" rating and a $437.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $395.82.

Molina Healthcare Price Performance

Shares of NYSE MOH traded down $3.20 during trading hours on Thursday, hitting $375.30. 434,414 shares of the stock were exchanged, compared to its average volume of 389,237. The company has a market cap of $21.99 billion, a PE ratio of 19.98, a price-to-earnings-growth ratio of 1.07 and a beta of 0.47. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.54 and a current ratio of 1.54. The company's fifty day simple moving average is $391.71 and its two-hundred day simple moving average is $368.02. Molina Healthcare has a 1-year low of $266.35 and a 1-year high of $423.92.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, February 7th. The company reported $4.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.31 by $0.07. Molina Healthcare had a net margin of 3.20% and a return on equity of 32.34%. The firm had revenue of $9.05 billion during the quarter, compared to analysts' expectations of $8.35 billion. During the same period last year, the company earned $4.10 earnings per share. The business's revenue was up 10.0% on a year-over-year basis. On average, sell-side analysts predict that Molina Healthcare will post 23.62 EPS for the current year.

Insiders Place Their Bets

In other news, CFO Mark Lowell Keim sold 15,000 shares of the company's stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the sale, the chief financial officer now directly owns 36,531 shares of the company's stock, valued at approximately $14,121,423.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Molina Healthcare news, Director Richard M. Schapiro sold 711 shares of the firm's stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the sale, the director now owns 12,207 shares in the company, valued at approximately $4,688,220.42. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Mark Lowell Keim sold 15,000 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the sale, the chief financial officer now directly owns 36,531 shares of the company's stock, valued at $14,121,423.36. The disclosure for this sale can be found here. In the last ninety days, insiders sold 16,711 shares of company stock worth $6,472,517. 1.10% of the stock is currently owned by corporate insiders.

Institutional Trading of Molina Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in the company. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in shares of Molina Healthcare in the third quarter worth $30,000. McIlrath & Eck LLC purchased a new position in shares of Molina Healthcare during the 4th quarter valued at about $34,000. Coppell Advisory Solutions Corp. purchased a new stake in shares of Molina Healthcare in the fourth quarter worth about $34,000. ST Germain D J Co. Inc. acquired a new stake in Molina Healthcare during the second quarter worth about $33,000. Finally, VisionPoint Advisory Group LLC lifted its position in Molina Healthcare by 105.6% during the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company's stock worth $36,000 after buying an additional 57 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.